Skip to content
FIND A BIOALPS ACTOR
Incepto

Incepto raised €27 million

20.09.2022
Share this article

The platform for artificial intelligence solutions applied to medical imaging, announces a €27 million round of financing. The goal: to treat one million patients in Europe per month by 2024.

 

Incepto, which has a branch office at the Biopôle Lausanne in Switzerland, has just raised €27 million in a financing round led by LBO France, with the participation of Wille Finance and its historical investors AXA Venture Partners (AVP), the Patient Autonomy fund of Bpifrance and Karista.

This financing marks a new step for Incepto, which is launching its offering in four new countries in Europe (Germany, Spain, Italy, and Portugal).

In 2018, we identified the need for a platform to accelerate the use of AI in healthcare, particularly in the fast-growing imaging space. In four years, we have participated in the emergence of a true disruptive technology and today our integrated solutions are used in all regions of France and benefit 100,000 patients every month. Our deeply European values, such as respect for data confidentiality, transparency and fair value sharing between stakeholders, are major assets for our development on the continent. We are proud to have convinced a number of well-informed investors to accompany us in our growth on a European scale. By 2024, one million patients in Europe will benefit from our artificial intelligence applications every month“, says Antoine Jomier, co-founder and President of Incepto.

 

New partners

Incepto also announces the signature of five new partnerships (IBlab, Milvue, PAIRE, Smartsoft and Thirona) to expand its portfolio of applications in medical imaging, emergency care, oncology, orthopedics, rheumatology and pneumology.

By extending its geographical coverage and developing its portfolio of applications, Incepto is responding to major public health challenges: reducing waiting times for examinations, compensating for the lack of specialists for certain serious diseases, and supporting doctors’ work in the face of the increasing amount of data to be analyzed, which makes it possible to rethink patient management in several care sectors, such as emergency, cancer, cardiology, and neurodegenerative diseases.

 

 About Incepto

Founded in 2018, Incepto is a platform for state-of-art AI enhanced solutions for medical imaging, providing a unified, fast, and secure customer experience. The company is addressing fundamental public health issues such as cancer and cardiovascular diseases, by improving the speed, and quality of diagnosis of these pathologies.

Already 100,000 patients benefit from the AI applications provided by the Incepto platform every month. The startup is currently working with more than 150 clients and reference radiology sites in France and Europe, including some 20 leading hospitals (AP-HP, Grenoble, Montpellier, Nancy, Poitiers, Rennes, etc.) and private networks such as France Imagerie Territoires, the 3R group, Elsan, Telediag and Affidea, the most recent partnership signed.